Innovations in Malaria Vaccine Development (IMV)
The summary for the Innovations in Malaria Vaccine Development (IMV) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Agency for International Development, which is the U.S. government agency offering this grant.
Innovations in Malaria Vaccine Development (IMV): USAID is seeking to enhance our malaria vaccine investments through a collaborative design process. The goal of USAID's Malaria Vaccine Development Program (MVDP) is to demonstrate the proof of concept of a vaccine to reduce morbidity and mortality due to malaria caused by infection with Plasmodium falciparum. Target malaria vaccine end characteristics will include at least 75% efficacy and evidence of affordability. USAID intends to support efforts towards vaccines that have the potential to directly protect recipients against disease caused by P. falciparum such as vaccines that target the pre-erythrocytic (sporozoite and liver stage) and erythrocytic stages of the life cycle. The purpose of this Addendum is to solicit Expressions of Interest (EOI) for novel and innovative approaches to malaria vaccine development that would encompass preclinical development through proof of principle clinical studies to motivate advanced development of a deployable, effective malaria vaccine.
Federal Grant Title: | Innovations in Malaria Vaccine Development (IMV) |
Federal Agency Name: | Agency for International Development (USAID) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | GH-BAA-2018-ADDENDUM03 |
Type of Funding: | Other |
CFDA Numbers: | 98.001 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | June 21st, 2019 |
Original Application Deadline: | June 21st, 2019 |
Posted Date: | May 17th, 2019 |
Creation Date: | May 17th, 2019 |
Archive Date: | July 21st, 2019 |
Total Program Funding: | |
Maximum Federal Grant Award: | $35,500,000 |
Minimum Federal Grant Award: | $0 |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | May 17th, 2019 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- Christie Cooper
Contract Specialist
[email protected] - Similar Government Grants
- • Community Mobilization Initiatives to End Tuberculosis 2 (COMMIT 2)
- • Private Sector Collaboration Pathway (PSCP) Jordan Addendum
- • Request For Information-Local Works Mozambique
- • Strengthening Economic and Socio-Cultural Resilience of Tibetan Communities in South Asia
- • NPI Annual Program Statement (New Partnerships Initiative (NPI)/Conflict Prevention and Re...
- • Textbook and Learning Materials Program
- • Field-Support Program
- • FY-2005 Disaster Response Initiative in Northeast Sudan
- • YODA-7200AA20APS00007_Addendum
- • Development Innovation Ventures: Stage 4 Awards Annual Program Statement (APS)
- • GH Social and Behavior Change (SBC) Activity
- • 2024-draft-ifrp-transport-rfa-draft